Erin Hahn to Female
This is a "connection" page, showing publications Erin Hahn has written about Female.
Connection Strength
0.914
-
Incidence of chronic medical conditions among survivors of adolescent and young adult cancer compared to a population without cancer. Cancer. 2025 Oct 15; 131(20):e70125.
Score: 0.079
-
Century-old chromatin architecture revealed in formalin-fixed vertebrates. Nat Commun. 2024 Jul 29; 15(1):6378.
Score: 0.073
-
Barriers and facilitators to implementation and sustainment of guideline-recommended depression screening for patients with breast cancer in medical oncology: a qualitative study. Support Care Cancer. 2023 Jul 12; 31(8):461.
Score: 0.068
-
Effect of a Community-Based Medical Oncology Depression Screening Program on Behavioral Health Referrals Among Patients With Breast Cancer: A Randomized Clinical Trial. JAMA. 2022 01 04; 327(1):41-49.
Score: 0.061
-
A Patient Portal-Based Commitment Device to Improve Adherence with Screening for Colorectal Cancer: a Retrospective Observational Study. J Gen Intern Med. 2021 04; 36(4):952-960.
Score: 0.057
-
Anxiety, Culture, and Expectations: Oncologist-Perceived Factors Associated With Use of Nonrecommended Serum Tumor Marker Tests for Surveillance of Early-Stage Breast Cancer. J Oncol Pract. 2017 01; 13(1):e77-e90.
Score: 0.043
-
Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care? Cancer. 2016 Mar 15; 122(6):908-16.
Score: 0.040
-
Use of imaging for staging of early-stage breast cancer in two integrated health care systems: adherence with a choosing wisely recommendation. J Oncol Pract. 2015 May; 11(3):e320-8.
Score: 0.038
-
Post-traumatic stress symptoms in cancer survivors: relationship to the impact of cancer scale and other associated risk factors. Psychooncology. 2015 Jun; 24(6):643-52.
Score: 0.036
-
Use of imaging and biomarker tests for posttreatment care of early-stage breast cancer survivors. Cancer. 2013 Dec 15; 119(24):4316-24.
Score: 0.034
-
Provider perceptions and expectations of breast cancer posttreatment care: a University of California Athena Breast Health Network project. J Cancer Surviv. 2013 Sep; 7(3):323-30.
Score: 0.033
-
Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol. 2008 Feb 10; 26(5):759-67.
Score: 0.023
-
Shared Identity and Patient Care: Adherence to Guideline-Recommended Biomarker Testing in Chronic Myeloid Leukemia. J Natl Compr Canc Netw. 2026 Mar; 24(3).
Score: 0.020
-
Test-Retest Reliability and Mode Effects on Single-Item and Multi-Item Measures in a Survey of Adolescent and Young Adults with Cancer. J Adolesc Young Adult Oncol. 2026 Oct; 15(5):340-346.
Score: 0.020
-
Metastatic Recurrence Among Adolescents and Young Adults With Cancer. JAMA Oncol. 2026 01 01; 12(1):75-83.
Score: 0.020
-
Repeated Independent Formation of Triploid Lineages Contributes to Clonal Diversity in Heteronotia binoei Parthenogens. Mol Ecol. 2026 Jan; 35(2):e70240.
Score: 0.020
-
Identifying Patterns of Late Effects With Latent Class Analysis Among Adolescent and Young Adult Thyroid Cancer Survivors in California and Utah. Cancer Med. 2025 Dec; 14(23):e71316.
Score: 0.020
-
Identifying clustering in patterns of late effects among survivors of adolescent and young adult Hodgkin lymphoma. JNCI Cancer Spectr. 2025 Nov 03; 9(6).
Score: 0.020
-
Evaluating Long-Term Health Disparity Impacts of Clinical Algorithms Using a Patient-Level Simulation Framework. Value Health. 2026 03; 29(3):357-365.
Score: 0.020
-
Trastuzumab therapy and new-onset hypertension in adolescents and young adults with breast cancer. Breast Cancer Res Treat. 2025 Aug; 213(1):81-92.
Score: 0.019
-
A pragmatic randomized trial to compare strategies for implementing?primary HPV testing for routine cervical cancer screening in a large?healthcare system. Implement Sci. 2025 May 12; 20(1):21.
Score: 0.019
-
Primary Human Papillomavirus Screening: Women's Perceptions of New Cervical Cancer Screening Recommendations. J Womens Health (Larchmt). 2024 Dec; 33(12):1614-1624.
Score: 0.018
-
Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing. Cancer Epidemiol Biomarkers Prev. 2024 Feb 06; 33(2):215-223.
Score: 0.018
-
Racial and Ethnic Bias in Risk Prediction Models for Colorectal Cancer Recurrence When Race and Ethnicity Are Omitted as Predictors. JAMA Netw Open. 2023 Jun 01; 6(6):e2318495.
Score: 0.017
-
A study protocol for a cluster randomized pragmatic trial for comparing strategies for implementing primary HPV testing for routine cervical cancer screening in a large health care system. Contemp Clin Trials. 2023 01; 124:106994.
Score: 0.016
-
Laboratory monitoring to reduce adverse drug-related events: a mixed methods study. J Manag Care Spec Pharm. 2022 Jan; 28(1):16-25.
Score: 0.015
-
Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21-65 Years in a Large Integrated Health Care System - Southern California, January 1-September 30, 2019, and January 1-September 30, 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 29; 70(4):109-113.
Score: 0.014
-
Personalized Cancer Follow-Up Care Pathways: A Delphi Consensus of Research Priorities. J Natl Cancer Inst. 2020 12 14; 112(12):1183-1189.
Score: 0.014
-
Follow-up of Abnormal Estimated GFR Results Within a Large Integrated Health Care Delivery System: A Mixed-Methods Study. Am J Kidney Dis. 2019 11; 74(5):589-600.
Score: 0.013
-
Comorbidity Profiles and Their Effect on Treatment Selection and Survival among Patients with Lung Cancer. Ann Am Thorac Soc. 2017 Oct; 14(10):1571-1580.
Score: 0.011
-
Quality of Posttreatment Care Among Breast Cancer Survivors in the University of California Athena Breast Health Network (Athena). Clin Breast Cancer. 2016 10; 16(5):356-363.
Score: 0.010